Clinical Study

A Long Term Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.

Posted Date: Jan 27, 2020

  • Investigator: Caleb Adler
  • Specialties: ADD/ADHD, Psychiatry/Psychology
  • Type of Study: Drug

An Open-label, 52-Week, Multicenter Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-Release Tablets in Adults with Attention-Deficit/Hyperactivity Disorder


Subjects Who Completed The 6-Week Double-Blind Treatment Study


Add, Adhd, Adult

For More Information:

Eimly Rummelhoff

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.